Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis

Figure 1

Differences in ventilation pulmonary dysfunction between NCFB patients with and without impaired pulmonary diffusing capacity diagnosed by DLCO <80% prediction (a), with and without impaired pulmonary diffusing capacity diagnosed by DLCO/VA <80% prediction (b), and with and without decreased alveolar volume by VA <80% prediction (c).

(a)

(b)

(c)